LEADER 02107nam  2200373   450 
001 9910674039703321
005 20230623085201.0
035   $a(CKB)4100000011302162
035   $a(NjHacI)994100000011302162
035   $a(EXLCZ)994100000011302162
100   $a20230623d2020      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMicrobial Biofilms in Healthcare $eFormation, Prevention and Treatment /$fKaren Vickery
210  1$aBasel :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2020.
215   $a1 online resource (166 pages)
311   $a3-03928-410-X 
330   $aBiofilms are ubiquitous and their presence in industry can lead to production losses. However, nowhere do biofilms impact human health and welfare as much as those that are found contaminating the healthcare environment, surgical instruments, equipment, and medical implantable devices. Approximately 70% of healthcare-associated infections are due to biofilm formation, resulting in increased patient morbidity and mortality. Biofilms formed on medical implants are recalcitrant to antibiotic treatment, which leaves implant removal as the principal treatment option. In this book, we investigate the role of biofilms in breast and dental implant disease and cancer. We include in vitro models for investigating treatment of chronic wounds and disinfectant action against Candida sp. Also included are papers on the most recent strategies for treating biofilm infection ranging from antibiotics incorporated into bone void fillers to antimicrobial peptides and quorum sensing.
517   $aMicrobial Biofilms in Healthcare
606   $aMedical microbiology
606   $aMedical bacteriology
615  0$aMedical microbiology.
615  0$aMedical bacteriology.
676   $a616.9041
700   $aVickery$b Karen$01368225
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910674039703321
996   $aMicrobial Biofilms in Healthcare$93393134
997   $aUNINA